BLCO Stock Price, Chart, Stats & News

Bausch + Lomb Corporation
Save
5.30B
Market cap
–
Current P/E
14.03x
Forward P/E
BLCO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 58.71% |
Operating margin | 3.12% |
Pretax margin | -6.21% |
Net margin | -7.06% |
Effective tax rate | -11.04% |
ROA | -2.57% |
ROE | -5.61% |
D/E | 0.83x |
Interest coverage ratio | 0.37x |
BLCO valuation
P/E | – |
P/S | 1.07x |
P/B | 0.84x |
P/CF | 19.19x |
P/FCF | -86.90x |
P/OCF | 19.19x |
PEG | 0.88x |
EV multiple | 0.80x |
About
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye.
Similar securities
Based on sector and market capitalization
Report issue











